- Home
- TVAI vs CADL Comparison
TVAI vs CADL Comparison
Compare TVAI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVAI
- CADL
- Stock Information
- Founded
- TVAI 2024
- CADL 1999
- Country
- TVAI United States
- CADL United States
- Employees
- TVAI N/A
- CADL N/A
- Industry
- TVAI
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- TVAI
- CADL Health Care
- Exchange
- TVAI NYSE
- CADL Nasdaq
- Market Cap
- TVAI 271.4M
- CADL 250.0M
- IPO Year
- TVAI 2025
- CADL 2021
- Fundamental
- Price
- TVAI $10.00
- CADL $6.29
- Analyst Decision
- TVAI
- CADL Strong Buy
- Analyst Count
- TVAI 0
- CADL 5
- Target Price
- TVAI N/A
- CADL $21.40
- AVG Volume (30 Days)
- TVAI 1.7K
- CADL 998.4K
- Earning Date
- TVAI 01-01-0001
- CADL 08-12-2025
- Dividend Yield
- TVAI N/A
- CADL N/A
- EPS Growth
- TVAI N/A
- CADL N/A
- EPS
- TVAI N/A
- CADL N/A
- Revenue
- TVAI N/A
- CADL N/A
- Revenue This Year
- TVAI N/A
- CADL N/A
- Revenue Next Year
- TVAI N/A
- CADL N/A
- P/E Ratio
- TVAI N/A
- CADL N/A
- Revenue Growth
- TVAI N/A
- CADL N/A
- 52 Week Low
- TVAI $10.02
- CADL $3.79
- 52 Week High
- TVAI $10.18
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- TVAI N/A
- CADL 51.41
- Support Level
- TVAI N/A
- CADL $6.35
- Resistance Level
- TVAI N/A
- CADL $7.21
- Average True Range (ATR)
- TVAI 0.00
- CADL 0.40
- MACD
- TVAI 0.00
- CADL -0.06
- Stochastic Oscillator
- TVAI 0.00
- CADL 15.78
About TVAI THAYER VENTURES ACQUISITION CORP II
Thayer Ventures Acquisition Corp II is a blank check company.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.